Written by Ijeoma UKAZU

Covid-19: People who recover are immune for 6 months

As the number of people who have fought off SARS-CoV-2 climbs ever higher, a critical question has grown in importance: How long will their immunity to the novel coronavirus last?

A new Rockefeller study offers an encouraging answer, suggesting that those who recover from COVID-19 are protected against the virus for at least six months, and likely much longer.

The findings, published in Nature, provide the strongest evidence yet that the immune system "remembers" the virus and, remarkably, continues to improve the quality of antibodies even after the infection has waned.

Antibodies produced months after the infection showed increased ability to block SARS-CoV-2, as well as its mutated versions such as the South African variant.

The researchers found that these improved antibodies are produced by immune cells that have kept evolving, apparently due to a continued exposure to the remnants of the virus hidden in the gut tissue.

Based on these findings, researchers suspect that when the recovered patient next encounters the virus, the response would be both faster and more effective, preventing re-infection.

 

"This is really exciting news. The type of immune response we see here could potentially provide protection for quite some time, by enabling the body to mount a rapid and effective response to the virus upon re-exposure," says Michel C. Nussenzweig, the Zanvil A. Cohn and Ralph M. Steinman, Professor and head of the Laboratory of Molecular Immunology, whose team has been tracking and characterizing antibody response in Covid-19 patients since the early days of the pandemic in New York.

Antibodies, which the body creates in response to infection, linger in the blood plasma for several weeks or months, but their levels significantly drop with time.

The immune system has a more efficient way of dealing with pathogens: instead of producing antibodies all the time, it creates memory B cells that recognize the pathogen, and can quickly unleash a new round of antibodies when they encounter it a second time.

"We were surprised to see the memory B cells had kept evolving during this time," Nussenzweig says. "That often happens in chronic infections, like HIV or herpes, where the virus lingers in the body. But we weren't expecting to see it with SARS-CoV-2, which is thought to leave the body after infection has resolved."

Sinai Hospital, who has been examining biopsies of intestinal tissue from people who had recovered from COVID-19 on average three months earlier.

In seven of the 14 individuals studied, tests showed the presence of SARS-CoV-2's genetic material and its proteins in the cells that line the intestines. The researchers don't know whether these viral left-overs are still infectious or are simply the remains of dead viruses.

 

Search

Latest posts

PhotoHow we achieved less road fatalities in FCT - Gora

Mr. Wobin Ayuba Gora is the Federal Capital Territory (FCT) Sector Commander of the Federal Road Safety Corps (FRSC). He is instrum [...]

22 February 2021

PhotoU.S. shores up fight against TB with diagnostic equipment

The fight against tuberculosis received a boost recently with the donation of 86,500 “GeneXpert Ultra” cartridges by the U.S. Agency fo [...]

22 February 2021